obinxchipalez's Blog

Short-read Sequencing Market Share and New Trends Analysis: By Its Type, Application, End-use and Forecast for period from 2024 to 2031

obinxchipalez's photo
obinxchipalez
·

5 min read

The "Short-read Sequencing Market" is focused on controlling cost, and improving efficiency. Moreover, the reports offer both the demand and supply aspects of the market. The Short-read Sequencing market is expected to grow annually by 8.3% (CAGR 2024 - 2031).

This entire report is of 171 pages.

Short-read Sequencing Introduction and its Market Analysis

Short-read sequencing is a technology used for rapid DNA sequencing, which is essential for genomics research, personalized medicine, and diagnostics. The target market for short-read sequencing includes academic research institutions, pharmaceutical companies, and clinical laboratories. Major factors driving revenue growth are increasing demand for personalized medicine, advancements in sequencing technologies, and decreasing costs. Companies such as Thermo Fisher Scientific, Hoffmann-La Roche AG, and Illumina dominate the market due to their innovative products and strong distribution networks. The market is highly competitive, with a focus on R&D and strategic partnerships. The report recommends investing in technologies such as next-generation sequencing for long-term growth and market leadership.

Get a Sample PDF of the Report: https://www.reliablebusinessinsights.com/enquiry/request-sample/1376525

The short-read sequencing market is experiencing significant growth, with a range of instruments, consumables, and services catering to academic research, clinical research, hospitals & clinics, pharma & biotech entities, and other segments. This technology allows for rapid and cost-effective sequencing of DNA and RNA, enabling advancements in genomics and personalized medicine.

Regulatory and legal factors play a crucial role in shaping market conditions for short-read sequencing. Compliance with regulations such as FDA approvals and data privacy laws is essential for companies operating in this space. Additionally, intellectual property rights and licensing agreements can impact market dynamics and competition among players.

Overall, the short-read sequencing market offers immense opportunities for innovation and collaboration across various sectors, driving advancements in healthcare and life sciences. With a strong focus on regulatory compliance and legal considerations, companies in this space can navigate challenges and capitalize on the growing demand for sequencing technologies.

Top Featured Companies Dominating the Global Short-read Sequencing Market

The Short-read Sequencing market is highly competitive with key players such as Thermo Fisher Scientific, Hoffmann-La Roche AG, GE Healthcare, Fasteris SA, BGI Genomics, Agilent Technologies, Genscript Biotech Corporation, Macrogen, Genewiz, Qiagen, and Illumina leading the market. These companies provide various sequencing platforms and services that cater to the growing demand for genetic analysis in research, clinical diagnostics, and personalized medicine.

Thermo Fisher Scientific offers the Ion Torrent sequencing platform, while Hoffmann-La Roche AG provides the sequencing solutions through its subsidiary, Roche Sequencing. GE Healthcare offers sequencing instruments and reagents for clinical and research applications. Companies like Fasteris SA and BGI Genomics specialize in providing sequencing services to researchers and clinicians.

Agilent Technologies, Genscript Biotech Corporation, Macrogen, Genewiz, Qiagen, and Illumina are also prominent players in the Short-read Sequencing market. These companies offer a range of sequencing products and services, including sequencing instruments, reagents, and sequencing services.

These companies drive the growth of the Short-read Sequencing market by continuously innovating their products and services to meet the evolving needs of researchers and clinicians. They invest in research and development to enhance sequencing technologies, improve sequencing accuracy, and reduce sequencing costs. Additionally, these companies collaborate with research institutions, hospitals, and biopharmaceutical companies to expand their customer base and market reach.

In terms of sales revenue, Illumina is a market leader with reported annual revenue of over $3 billion. Thermo Fisher Scientific, Qiagen, and Roche Sequencing also generate substantial revenue from their sequencing products and services. These companies' strong financial performance reflects the growing demand for Short-read Sequencing technology and the expanding market opportunities in genomics research and precision medicine.

  • Thermo Fisher Scientific
  • Hoffmann-La Roche AG
  • GE healthcare
  • Fasteris SA
  • BGI Genomics
  • Agilent Technologies
  • Genscript Biotech Corporation
  • Macrogen
  • Genewiz
  • Qiagen
  • Illumina

Get a Sample PDF of the Report: https://www.reliablebusinessinsights.com/enquiry/request-sample/1376525

Short-read Sequencing Market Analysis, by Type:

  • Instruments
  • Consumables
  • Services

Short-read sequencing instruments include Illumina's MiSeq and NextSeq, while consumables such as reagents and sequencing chips are essential for sample preparation. Service providers, like Novogene and BGI, offer sequencing services to researchers. These types of equipment and services help boost demand for short-read sequencing by providing cost-effective, high-throughput solutions for genetic analysis. Researchers can quickly generate large amounts of sequencing data, accelerating genomic research and personalized medicine applications. As the demand for genomic data continues to grow, the short-read sequencing market is expected to expand significantly.

Inquire or Share Your Questions If Any Before the Purchasing This Report -https://www.reliablebusinessinsights.com/enquiry/pre-order-enquiry/1376525

Short-read Sequencing Market Analysis, by Application:

  • Academic Research
  • Clinical Research
  • Hospitals & Clinics
  • Pharma & Biotech Entities
  • Other

Short-read sequencing is used in academic research to study genomics, gene expression, and genetic variation. In clinical research, it helps identify disease-causing mutations and personalize treatment. Hospitals and clinics use it for diagnostic testing and disease monitoring. Pharma & biotech companies employ it for drug development and understanding disease mechanisms. Other applications include agriculture, forensic analysis, and environmental studies. The fastest growing application segment in terms of revenue is clinical research, as the demand for personalized medicine and precision healthcare continues to rise, driving increased use of short-read sequencing for diagnostic and therapeutic purposes.

Purchase this Report (Price 3250 USD for a Single-User License): reliablebusinessinsights.com/purchase/1376525

Short-read Sequencing Industry Growth Analysis, by Geography:

North America:

  • United States
  • Canada

Europe:

  • Germany
  • France
  • U.K.
  • Italy
  • Russia

Asia-Pacific:

  • China
  • Japan
  • South Korea
  • India
  • Australia
  • China Taiwan
  • Indonesia
  • Thailand
  • Malaysia

Latin America:

  • Mexico
  • Brazil
  • Argentina Korea
  • Colombia

Middle East & Africa:

  • Turkey
  • Saudi
  • Arabia
  • UAE
  • Korea

The short-read sequencing market is experiencing significant growth in regions such as North America (United States, Canada), Europe (Germany, France, ., Italy, Russia), Asia-Pacific (China, Japan, South Korea, India, Australia, Indonesia, Thailand, Malaysia), Latin America (Mexico, Brazil, Argentina, Colombia), and Middle East & Africa (Turkey, Saudi Arabia, UAE). The Asia-Pacific region is expected to dominate the market with a market share of 30%, followed by North America with 25% market share and Europe with 20% market share. Latin America and Middle East & Africa are projected to hold smaller market shares of 10% and 5% respectively.

Purchase this Report (Price 3250 USD for a Single-User License): reliablebusinessinsights.com/purchase/1376525

Check more reports on reliablebusinessinsights.com